These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23079809)

  • 1. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
    Suneja G; Shiels MS; Melville SK; Williams MA; Rengan R; Engels EA
    AIDS; 2013 Jan; 27(3):459-68. PubMed ID: 23079809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer treatment disparities in HIV-infected individuals in the United States.
    Suneja G; Shiels MS; Angulo R; Copeland GE; Gonsalves L; Hakenewerth AM; Macomber KE; Melville SK; Engels EA
    J Clin Oncol; 2014 Aug; 32(22):2344-50. PubMed ID: 24982448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
    Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
    Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care?
    Lee JY; Moore PC; Steliga MA
    Med Care; 2013 Dec; 51(12):1063-8. PubMed ID: 24220684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
    Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B
    Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care of nonsmall cell lung cancer patients in China and implications for survival.
    He Y; Yu XQ; Luo Q; Xu X; Wang Y; Li S; Shan B
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S410-S415. PubMed ID: 29970698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of racial disparities in early-stage lung cancer treatment.
    Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
    Yorio JT; Yan J; Xie Y; Gerber DE
    Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis in HIV-infected patients with non-small cell lung cancer.
    Sigel K; Crothers K; Dubrow R; Krauskopf K; Jao J; Sigel C; Moskowitz A; Wisnivesky J
    Br J Cancer; 2013 Oct; 109(7):1974-80. PubMed ID: 24022194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.
    Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M
    J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.
    Marcus JL; Chao C; Leyden WA; Xu L; Yu J; Horberg MA; Klein D; Towner WJ; Quesenberry CP; Abrams DI; Silverberg MJ
    Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1167-73. PubMed ID: 25713023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer incidence and survival among HIV-infected and uninfected women and men.
    Hessol NA; Martínez-Maza O; Levine AM; Morris A; Margolick JB; Cohen MH; Jacobson LP; Seaberg EC
    AIDS; 2015 Jun; 29(10):1183-93. PubMed ID: 25888645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in cancer treatment among patients infected with the human immunodeficiency virus.
    Suneja G; Lin CC; Simard EP; Han X; Engels EA; Jemal A
    Cancer; 2016 Aug; 122(15):2399-407. PubMed ID: 27187086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
    Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care.
    Brock MV; Hooker CM; Engels EA; Moore RD; Gillison ML; Alberg AJ; Keruly JC; Yang SC; Heitmiller RF; Baylin SB; Herman JG; Brahmer JR
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):47-55. PubMed ID: 16936558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.